Literature DB >> 25950452

Association of prematurity with the development of infantile hypertrophic pyloric stenosis.

Christopher M Stark1, Philip L Rogers2, Matthew D Eberly3, Cade M Nylund3.   

Abstract

BACKGROUND: Infantile hypertrophic pyloric stenosis (IHPS) has several known risk factors. The association between prematurity and IHPS and the timeline of presentation are poorly defined. Our aim was to evaluate the associations between IHPS and prematurity.
METHODS: We performed a retrospective cohort study of 1,074,236 children born between June 2001 and April 2012 in the US Military Health System. IHPS cases and gestational ages (GA) were identified using billing codes. Additional risk factors for IHPS were controlled for in a multivariable logistic regression model.
RESULTS: The incidence of IHPS was 2.99 per 1,000 in preterm infants and 2.25 per 1,000 in full term (relative risk (RR) = 1.33, 95% confidence interval (CI) 1.16-1.54). The adjusted odds ratio for prematurity was 1.26 (95% CI 1.08-1.46). The median (interquartile range (IQR)) chronological age at presentation was 40 d (30-56) in preterm infants vs. 33 d (26-45) in full term (P < 0.001). Median postmenstrual age at presentation was 42 wk in preterm infants (40-42) vs. 45 wk (44-46) in full term (P < 0.001).
CONCLUSION: Prematurity is associated with IHPS. Premature infants develop IHPS at a later chronological age, but earlier postmenstrual age, than term infants. Providers should have an increased concern for IHPS development in premature infants.

Entities:  

Mesh:

Year:  2015        PMID: 25950452     DOI: 10.1038/pr.2015.92

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  27 in total

1.  Clinical observations on pyloric stenosis in premature infants.

Authors:  J L HENDERSON; J J M BROWN; W C TAYLOR
Journal:  Arch Dis Child       Date:  1952-04       Impact factor: 3.791

2.  Novel noninvasive anthropometric measure in preterm and full-term infants: normative values for waist circumference:length ratio at birth.

Authors:  Alexander Holston; Theophil Stokes; Cara Olsen; Y Sammy Choi; Jerri Curtis; Jason Higginson; Chinenye Adimora; Carl E Hunt
Journal:  Pediatr Res       Date:  2013-06-24       Impact factor: 3.756

3.  Azithromycin in early infancy and pyloric stenosis.

Authors:  Matthew D Eberly; Matilda B Eide; Jennifer L Thompson; Cade M Nylund
Journal:  Pediatrics       Date:  2015-03       Impact factor: 7.124

4.  Infantile hypertrophic pyloric stenosis before 3 weeks of age in infants and preterm babies.

Authors:  I-Fei Huang; Mao-Meng Tiao; Christine C Chiou; Hsiang-Hung Shih; Hong-Hsiang Hu; Javier Perez Ruiz
Journal:  Pediatr Int       Date:  2011-02       Impact factor: 1.524

5.  Maternal and pregnancy characteristics and risk of infantile hypertrophic pyloric stenosis.

Authors:  Anna Svenningsson; Tobias Svensson; Olof Akre; Agneta Nordenskjöld
Journal:  J Pediatr Surg       Date:  2014-02-10       Impact factor: 2.545

6.  Pyloric stenosis: a retrospective study of an Australian population.

Authors:  Lisa M Gotley; A Blanch; R Kimble; K Frawley; Jason P Acworth
Journal:  Emerg Med Australas       Date:  2009-10       Impact factor: 2.151

7.  Gastric outlet obstruction after long-term prostaglandin administration mimicking hypertrophic pyloric stenosis.

Authors:  M Lacher; K Schneider; R Dalla Pozza; D V Schweinitz
Journal:  Eur J Pediatr Surg       Date:  2007-10       Impact factor: 2.191

8.  The epidemiology of infantile hypertrophic pyloric stenosis in a Danish population, 1950-84.

Authors:  L Rasmussen; A Green; L P Hansen
Journal:  Int J Epidemiol       Date:  1989-06       Impact factor: 7.196

9.  Bottle-feeding and the Risk of Pyloric Stenosis.

Authors:  Camilla Krogh; Robert J Biggar; Thea K Fischer; Morten Lindholm; Jan Wohlfahrt; Mads Melbye
Journal:  Pediatrics       Date:  2012-09-03       Impact factor: 7.124

10.  Prolonged prostaglandin E1 therapy in a neonate with pulmonary atresia and ventricular septal defect and the development of antral foveolar hyperplasia and hypertrophic pyloric stenosis.

Authors:  Tina Perme; Senja Mali; Ivan Vidmar; Diana Gvardijančič; Robert Blumauer; David Mishaly; Iztok Grabnar; Gregor Nemec; Stefan Grosek
Journal:  Ups J Med Sci       Date:  2013-03-22       Impact factor: 2.384

View more
  6 in total

1.  Prevalence and descriptive epidemiology of infantile hypertrophic pyloric stenosis in the United States: A multistate, population-based retrospective study, 1999-2010.

Authors:  Renuka Kapoor; Vijaya Kancherla; Yanyan Cao; Jacob Oleson; Jonathan Suhl; Mark A Canfield; Charlotte M Druschel; Russell S Kirby; Robert E Meyer; Paul A Romitti
Journal:  Birth Defects Res       Date:  2018-12-13       Impact factor: 2.344

2.  Laparoscopic pyloromyotomy for hypertrophic pyloric stenosis: a survey of 407 children.

Authors:  Aurélien Binet; C Klipfel; P Meignan; F Bastard; A R Cook; K Braïk; A Le Touze; T Villemagne; M Robert; Q Ballouhey; F Lengelle; S Amar; H Lardy
Journal:  Pediatr Surg Int       Date:  2018-02-06       Impact factor: 1.827

3.  Application of color Doppler ultrasound combined with Doppler imaging artifacts in the diagnosis and estimate of congenital hypertrophic pyloric stenosis.

Authors:  Suihong Ma; Jianhua Liu; Youxiang Zhang; Yuwen Yang; Hai Jin; Xiaomei Ma; Hongqin Wei
Journal:  Sci Rep       Date:  2017-08-25       Impact factor: 4.379

Review 4.  Differential diagnosis of perinatal Bartter, Bartter and Gitelman syndromes.

Authors:  Oluwatoyin Fatai Bamgbola; Youssef Ahmed
Journal:  Clin Kidney J       Date:  2020-10-25

5.  Randomised trial of azithromycin to eradicate Ureaplasma in preterm infants.

Authors:  Rose Marie Viscardi; Michael L Terrin; Laurence S Magder; Natalie L Davis; Susan J Dulkerian; Ken B Waites; Namasivayam Ambalavanan; David A Kaufman; Pamela Donohue; Deborah J Tuttle; Jorn-Hendrik Weitkamp; Hazem E Hassan; Natalie D Eddington
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2020-03-13       Impact factor: 5.747

6.  Randomized trial of azithromycin to eradicate Ureaplasma respiratory colonization in preterm infants: 2-year outcomes.

Authors:  Rose M Viscardi; Michael L Terrin; Laurence S Magder; Natalie L Davis; Susan J Dulkerian; Ken B Waites; Marilee Allen; Ajoke Ajayi-Akintade; Namasivayam Ambalavanan; David A Kaufman; Pamela Donohue; Deborah J Tuttle; Jörn-Hendrik Weitkamp
Journal:  Pediatr Res       Date:  2021-03-03       Impact factor: 3.756

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.